BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 1372091)

  • 1. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors.
    Hu P; Margolis B; Skolnik EY; Lammers R; Ullrich A; Schlessinger J
    Mol Cell Biol; 1992 Mar; 12(3):981-90. PubMed ID: 1372091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.
    McGlade CJ; Ellis C; Reedijk M; Anderson D; Mbamalu G; Reith AD; Panayotou G; End P; Bernstein A; Kazlauskas A
    Mol Cell Biol; 1992 Mar; 12(3):991-7. PubMed ID: 1372092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells.
    Kavanaugh WM; Klippel A; Escobedo JA; Williams LT
    Mol Cell Biol; 1992 Aug; 12(8):3415-24. PubMed ID: 1321334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.
    Klippel A; Escobedo JA; Fantl WJ; Williams LT
    Mol Cell Biol; 1992 Apr; 12(4):1451-9. PubMed ID: 1312663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes.
    Roche S; Dhand R; Waterfield MD; Courtneidge SA
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):703-11. PubMed ID: 7519847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase.
    Cooper JA; Kashishian A
    Mol Cell Biol; 1993 Mar; 13(3):1737-45. PubMed ID: 8382774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
    Nishimura R; Li W; Kashishian A; Mondino A; Zhou M; Cooper J; Schlessinger J
    Mol Cell Biol; 1993 Nov; 13(11):6889-96. PubMed ID: 7692233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85.
    Yamamoto K; Altschuler D; Wood E; Horlick K; Jacobs S; Lapetina EG
    J Biol Chem; 1992 Jun; 267(16):11337-43. PubMed ID: 1317864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine.
    Escobedo JA; Kaplan DR; Kavanaugh WM; Turck CW; Williams LT
    Mol Cell Biol; 1991 Feb; 11(2):1125-32. PubMed ID: 1703628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.
    Meisenhelder J; Suh PG; Rhee SG; Hunter T
    Cell; 1989 Jun; 57(7):1109-22. PubMed ID: 2472219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 subunit to tyrosine-phosphorylated PDGF receptor.
    McGuire TF; Corey SJ; Sebti SM
    J Biol Chem; 1993 Oct; 268(30):22227-30. PubMed ID: 7693661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor.
    Escobedo JA; Navankasattusas S; Kavanaugh WM; Milfay D; Fried VA; Williams LT
    Cell; 1991 Apr; 65(1):75-82. PubMed ID: 1849460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha.
    Stover DR; Becker M; Liebetanz J; Lydon NB
    J Biol Chem; 1995 Jun; 270(26):15591-7. PubMed ID: 7797556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling.
    Rani CS; Wang F; Fuior E; Berger A; Wu J; Sturgill TW; Beitner-Johnson D; LeRoith D; Varticovski L; Spiegel S
    J Biol Chem; 1997 Apr; 272(16):10777-83. PubMed ID: 9099730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions.
    Heidaran MA; Beeler JF; Yu JC; Ishibashi T; LaRochelle WJ; Pierce JH; Aaronson SA
    J Biol Chem; 1993 May; 268(13):9287-95. PubMed ID: 8387491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta.
    Rui L; Carter-Su C
    J Biol Chem; 1998 Aug; 273(33):21239-45. PubMed ID: 9694882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements of the epidermal growth factor receptor for tyrosine phosphorylation of eps8 and eps15, substrates lacking Src SH2 homology domains.
    Alvarez CV; Shon KJ; Miloso M; Beguinot L
    J Biol Chem; 1995 Jul; 270(27):16271-6. PubMed ID: 7608194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SH2/SH3 domain-containing protein Nck is recognized by certain anti-phospholipase C-gamma 1 monoclonal antibodies, and its phosphorylation on tyrosine is stimulated by platelet-derived growth factor and epidermal growth factor treatment.
    Meisenhelder J; Hunter T
    Mol Cell Biol; 1992 Dec; 12(12):5843-56. PubMed ID: 1448108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
    J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.